22 May 2013
Keywords: alnylam, closes, rnai, deal, roche, pharmaceuticals, leading
Article | 20 August 2007
Alnylam Pharmaceuticals, a leading US RNAi therapeutics company, says it has closed its previously-announced alliance with Swiss drug major Roche
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 August 2007
21 May 2013
© 2013 thepharmaletter.com